CytoMed Therapeutics (GDTC) Enterprise Value (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Enterprise Value of -$1.6 million for Q4 2025, up 65.01% sequentially from -$4.6 million in Q2 2025, and up 55.81% YoY from -$1.0 million in Q4 2024.
CytoMed Therapeutics (GDTC) Enterprise Value (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Enterprise Value for 5 years, with the latest figure at -$1.6 million in Q4 2025.
- Quarterly Enterprise Value rose 55.81% year-over-year to -$1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.6 million (up 55.81% YoY) and the FY2025 annual result came in at -$1.6 million, up 55.97% from the prior year.
- Enterprise Value grew to -$1.6 million in Q4 2025 per GDTC's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.1 million in Q4 2022 and troughed at -$10.4 million in Q2 2023.
- A 5-year average of -$4.6 million and a median of -$3.7 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value tumbled 485.05% in 2023, then jumped 55.81% in 2025.
- Over 5 years, Enterprise Value stood at -$1.9 million in 2021, then surged by 38.49% to -$1.1 million in 2022, then sank by 485.05% to -$6.7 million in 2023, then surged by 45.09% to -$3.7 million in 2024, then surged by 55.81% to -$1.6 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$1.6 million, -$4.6 million, and -$3.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 2.12 Bn |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - | -1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.62 Mn |
| Jun 30, 2025 | -4.62 Mn |
| Dec 31, 2024 | -3.66 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Dec 31, 2023 | -6.66 Mn |
| Jun 30, 2023 | -10.44 Mn |
| Dec 31, 2022 | -1.14 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Dec 31, 2021 | -1.85 Mn |